“Acute lymphadenitis”的搜索结果，显示 201-210 项，共有 9237 项

1. 血液科- 临床试验- 妙佑医疗国际

   This phase III trial studies whether inotuzumab ozogamicin added to post-induction chemotherapy for patients with High-Risk B-cell Acute Lymphoblastic Leukemia ...

2. 血液科- 临床试验- 妙佑医疗国际

   ... acute setting and infections and financial burden in the long-term setting, a longitudinal study that assesses these issues in a quantitative and ...

3. 肿瘤科（内科） - 临床试验- 妙佑医疗国际

   The purpose of this study is to evaluate immune profile of Acute Myeloid Leukemia (AML) patients receiving Venetoclax plus Azacitidine induction chemotherapy.

4. 肿瘤科（内科） - 临床试验- 妙佑医疗国际

   This phase III trial studies whether inotuzumab ozogamicin added to post-induction chemotherapy for patients with High-Risk B-cell Acute Lymphoblastic Leukemia ...

5. 肿瘤科（内科） - 临床试验- 妙佑医疗国际

   The purpose of this study is to evaluate immune profile of Acute Myeloid Leukemia (AML) patients receiving Venetoclax plus Azacitidine induction chemotherapy.

6. 放射科- 临床试验- 妙佑医疗国际

   VERIFY will validate biomarkers of upper extremity (UE) motor outcome in the acute ischemic stroke window for immediate use in clinical trials, and explore ...

7. 血液科- 临床试验- 妙佑医疗国际

   This phase III trial studies whether inotuzumab ozogamicin added to post-induction chemotherapy for patients with High-Risk B-cell Acute Lymphoblastic Leukemia ...

8. 淋巴结肿大- 诊断与治疗- 妙佑医疗国际

   Lymphadenopathy. Merck Manual Professional Version. https://www.merckmanuals ... Papadakis MA, et al., eds. Lymphangitis and lymphadenitis. In: Current ...

9. 血管中心- 临床试验- 妙佑医疗国际

   Spontaneous coronary artery dissection (SCAD) is uncommon but important cause of acute coronary syndrome and sudden cardiac death. ... acute kidney injury in high ...

10. 肿瘤科（内科） - 临床试验- 妙佑医疗国际

    ... Acute Lymphoblastic Leukemia (ALL). Cell, Serum, and Buccal Bank for Patients with Chronic Myeloid Disorders and Acute Leukemia. Rochester, Minn. This study ...